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INTRODUCTION

The administration of lithium has been advocated for the
treatment of a variety of diseases during the last one hundred
years.

Most of these applications are now considered useless;

however, the discovery that lithium salts are prophylactic in the
treatment of affective disorders of the central nervous system has
stimulated a considerable amount of research on their biologic
effects.

Several excellent reviews

1-3

have summarized the effects

of lithium on various biologic systems.
The ability of lithium chloride to inhibit gastric secretion as
well as ulceration in the rat was discovered in this laboratory.
The possible mechanisms through which lithium mediates these
effects forms the basis of this paper.

1
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MATERIALS AND METHODS

Gastric Secretion Studies
Female Upjohn rats (derived from the Sprague-Dawley strain),
weighing 195-210 gm, were used in all experiments.

Food, but not

water, was withheld from the animals (starting at 3:30 a.m.)
24 hours prior to study.

On the night prior to experimentation the

rats were placed in cylindrical stainless steel tubes to prevent
them from bending.

They were thus unable to consume hair and

feces which may contaminate the gastric juice.

This type of re

straining device has not proved stressful and has been described
elsewhere.^
On the morning of study, lost body fluids from fasting were
replaced with the administration of 10 ml saline subcutaneously.

It

was observed that rats drank very little when deprived of food and
lost approximately 10 gm during food deprivation.

Two hours after

the saline administration, the pylorus was ligated under ether
anesthesia.

Four hours after pylorus ligation,

the animals were

killed with C 0 2 » their stomachs were removed, and the accumulated
gastric juice was collected.
The volume of gastric juice was measured in a graduated cen
trifuge tube to the nearest 0.1 ml; acid was titrated with 0.1 N
NaOH to pH 7 with the use of a glass electrode (Copenhagen radio
meter) and expressed in mEq/L (concentration) and mEq/4 hr (output).
Pepsin content was determined by the hemoglobin method,"* as modified

2
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3

by Vatier and colleagues,^ for an autoanalyzer.

Pepsin was

expressed as yEq tyrosine/ml (concentration) and yEq tyrosine/4 hr
(output).
Lithium Chloride (LiCl) or sodium chloride was administered
either orally using a gastric tube (in 1 ml water) or subcutaneously
(in 2 ml water) at the following doses:
1.25, 1.5, 1.75 and 2.0 mMoles.

0.1, 0.25, 0.5, 0.75, 1.0,

Each agent was administered at

various times prior to pylorus ligation:

0, 2, 6, 12, and 18 hours.

In all experiments water controls were used for oral treatment,
whereas saline controls were used for subcutaneous treatment.

At

the 0-hour administration time, the salts were injected immediately
following pylorus ligation while the animals were still under ether
anesthesia.

For convenience, the administration

timesshall be

referred to as 0 hour, -2 hour, -6 hour, etc.
Determination of Ions in Serum and Gastric Juice
Under ether anesthesia, aortic blood was withdrawn and Li+
concentration determined.

The blood was permitted to clot overnight

at 4°C, after which it was centrifuged at 3000X g for 15 minutes.
Serum and gastric juice samples were analyzed utilizing an atomic
absorption spectrophotometer (Jarrell-Ash, model 82526).

Values of

Li+ , K+ , and Na+ were expressed in mEq/L (concentration) and mEq/4
hr (output).
Shay Ulcer Studies
The Shay rat was prepared according to the method of Shay and
associates,

7

as modified by Robert and associates.

8

Lithium
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chloride was administered either orally or subcutaneously in various
doses, i.e., 0.75, 1.0, and 1.5 mMoles, two hours prior to pylorus
ligation; rats were autopsied 22 hours after pylorus ligation.
Stomachs were removed, opened along the greater curvature, and
examined with the aid of 2X binoculars for the presence of fore
stomach ulcerations.
recorded.

The presence of gastric perforations was also

Percent incidence of animals with ulcers and with

perforations was recorded.
Statistical Tests
Results were expressed as percent of control (figures), or
percent from control (tables) so that different experiments could
be statistically compared.

Significance for ulcer studies was

determined using the Chi Square test.

Tae Student 't' test (with

pooled variance) was applied to observations within an experiment,
whereas whole sets of observations were compared using the Sign
q
test.

Statistical differences with p values less than 0.05 were

considered significant.
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RESULTS

Gastric Secretion Studies
Lithium chloride reduced acid concentration and acid output in
a dose-related manner after both oral and subcutaneous administra
tion, regardless of the time of treatment, i.e., 0 hr or -2 hr,
(Table 1).

As shown in Figure 1 (p. 6), the antisecretory effects of

LiCl were long-lasting; one mMole LiCl administered subcutaneously at
-18 hour significantly reduced acid concentration and acid output.

TabZe Z.

Acid concentration and output for oral and subcutaneous
administration of graded doses of LiCl at 0 hour and -2
hour.
Results are expressed as percent change from control.
Each number represents the mean value from ten rats.
(* = significant >_0.05 level)

Route and administration time

mMoles LiCl
.5
1.0

.1

1.5

2.0

Oral
0 hr

-2 hr

concentration
S.E.

+ 3
±3.4

-27*
±3.9

-46*
±1.1

output
S.E.

+25*
±9.6

-10
±9.6

-14
±5.4

concentration
S.E.

+14
±2.8

-25*
±9.8

-54*
±3.2

—

output
S.E.

+17
±9.0

-34*
±18.5

-51*
±7.3

—

-16*
±4.7

-93*
±1.5

-99*
±0.9

-95*
±3.0

-95*
±1.4

-72*
±7.4

-98*
±0.6

-99*
±0.4

-99*
±0.8

-99*
±0.4

+ 1
±3.4

-28*
±6.3

-74*
±3.2

-93*
±1.2

-97*
±0.9

- 1
±15.0

-55*
±6.0

-84*
±2.7

-95*
±0.7

-98*
±0.5

Subcut:aneous
concentration
S.E.
0 hr
output
S.E.
concentration
S.E.
-2 hr

output
S.E.

-

-

-

—

5
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-93*
±2.6
-93*
±2.9
-93*
±2.4
-92*
±2.7
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Figure I. Duration of action of LiCl antisecretory effect.
Mean decrease in acid concentration and output expressed as
percent of control is shown as LiCl is given at various
times prior to pylorus ligation.
Each column represents
the mean value from 12 rats. (For all figures, verticle
bars indicate standard error and the asterisk [*] indicates
significance above the 0.05 level.)

Pepsin concentration and output were reduced in a dose-related
manner after oral administration at -2 hour and 0 hour (Fig. 2a, p. 7).
Subcutaneous administration, on the other hand, reduced the pepsin
concentration and output in a dose-related manner at the -2 hour,
but not the 0-hour administration time (Fig. 2b, p. 7).

The reduction

in pepsin output at 0 hour was due to a decrease in the volume of
gastric juice as indicated by the relatively small change in pepsin
concentration at 0 hour.

Subcutaneous administration at the 0, -6,

-12, and -18 hour administration times significantly decreased pepsin
output but did not affect pepsin concentration, although both concen
tration and output were significantly reduced at -2 hour (Fig. 3, p. 8).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

7

129

100

a
cc
£
o
u
IA
.
o
►
—

s

CONC

20

-

OUTPUT
:* -2 HR

120

100
CONC.

3E

O UTPUT

0

0

HR.

HR.

CONC. • 2 H R .
O UTPUT - 2 HR.

1.75

Figure 2a S b. Pepsin content after oral (a) and
subcutaneous (b) administration of LiCl. Mean
decrease in pepsin concentration and output ex
pressed as percent of control is shown as a function
of various doses of LiCl given at 0 hour and -2
hour.
Each point represents the mean value
from 10 rats.
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1J laMafa LiQ

F-Lgupe 3.
Effect of subcutaneous administration
of LiCl on pepsin concentration and output are
expressed as percent of control.
Each column
represents the mean value from 12 rats.

The volume of gastric juice was significantly reduced after
subcutaneous administration (Fig. 4a, p. 9), but was unchanged or
even slightly increased after oral administration (Fig. 4b, p. 9).
Whenever LiCl was administered at -2 hour, either orally or
subcutaneously, the gastric juice was yellow, suggesting bile reflux.
To explore this possibility, gastric juice secreted from rats
receiving LiCl subcutaneously at either -2 hour or 0 hour was compared.
When LiCl was administered subcutaneously at 0 hour, that is, imme
diately after pylorus ligation,
bile staining,

1) the gastric juice did not exhibit

2) the volume of the gastric juice was significantly

reduced (according to the Sign test [Fig. 4a, p. 9]), and

3) the

pepsin concentration was not reduced (Fig. 2b, p. 7), whereas it was

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 4a & b. Volume of gastric juice after
subcutaneous (a) and oral (b) administration of
LiCl. Volume, expressed as percent of control,
is shown as a function of various doses of LiCl
given at 0 hour and -2 hour.
Each point represents
the mean value from 10 rats.
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reduced at 0 hour after oral administration (Fig. 2a, p. 7).

A bile

reflux was not observed after NaCl administration.
Both LiCl and NaCl (0.5-2.0 mMole) reduced acid and pepsin (con
centration and output) after oral administration, whereas only LiCl
was antisecretory after subcutaneous administration.

After oral admin

istration at 0 hour, both salts demonstrated equal potency in reducing
acid concentration and output (Fig. 5a, p. 11) and pepsin concentration
and output (Fig. 5b, p. 11).

When the salts were administered at

-2 hour, however, LiCl was more antisecretory than NaCl; LiCl reduced
both acid (Fig. 6a, p. 12) and pepsin (Fig. 6b, p. 12) more signifi
cantly (according to the Sign test) than did NaCl.
Determination of Ions in Serum and Gastric
Oral administration of LiCl at 0 hour
increase in sodium (Na+ ) concentration and

Juice
produced a dose-related
output and Li+ concentration

and output and a decrease in potassium (K+ ) concentration and output
in gastric juice (Table 2, p. 13).

When LiCl was administered orally

at -2 hour, Li+ serum concentration was significantly higher than when
administered orally at 0 hour (according to the Sign test [Fig. 7,
p. 14]).

Furthermore, when 1.0 mMole LiCl was administered subcuta

neously, Li+ concentrations in gastric juice were more than twice as
high as serum concentrations regardless of the time of LiCl administra
tion (Fig. 8, p. 14).

Subcutaneous administration of LiCl (1.0 mMole)

at various times prior to pylorus ligation, i.e., 0 hour, -2 hour,
-6 hour, -12 hour, and -18 hour, increased Na+ concentration and
output in gastric juice (Table 3, p. 15).

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

11

120

o
ec
o

u
o

OUTPUT
CONC

m M ofas L iQ o r N«C1

120r

100

e

oe

&

8
u.
O

OUTPUT

s
u
§

iwa
CONC

ua

n H W n U S o r N aO

Figure 5a & b.
Comparison of oral administration
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control are shown as a function of various doses
of the salts.
Each point represents the mean
value from eight rats.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

12

120

100

O

s

OUTPUT

u.

©
5
©
3
6

CONC.

UQ
raMotes U Q or KaCl

120

100

-

f-

CONC.

O
o
o
e
£W
I
a

OUTPUT

3

a.

CONC.

ua
■MdnUOarlha

Figure 6a & b.
Comparison of oral administration
of LiCl and NaCl on acid (a) and pepsin (b) content
at -2 hour. Mean decrease in acid and pepsin (con
centration and output) expressed as percent of
control are shown as a function of various doses
of the salts.
Each point represents the mean
value from eight rats.

R eproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 2.

Concentration and output of various ions in gastric juice after oral administration of graded
doses of lithium chloride at 0 hr. Concentration and output of ions are expressed as mEq/L
and mEq/4 hr respectively.
Each numeral represents the mean value from eight rats.
Numerals to the right indicate standard error. (* = significant >0.05 level)

Concentration and
output of ions

Water

.1

mMoles LiCl
.25

.5

1.0

2.0

Gastric juice
H+

mEq/L
mEq/4 hr

112.1±3.9
.839+0.1

115.513.9
1.116*10.1

96.9*15.4
.679+0.0

81.3*14.4
.754+0.1

60.7*11.3
.724+0.1

7.4*12.9
.060*10.0

Na+

mEq/L
mEq/4 hr

28.5+1.9
.217±0.0

24.2+1.6
.23710.0

28.0+1.9
.192+0.0

34.2+3.5
.32510.1

47.9*11.4
.576*10.1

68.9*11.3
.520*10.0

K+

mEq/L
mEq/4 hr

8.8510.6
.064+0.0

7.87+0.6
.078+0.0

9.20+0.5
.062+0.0

6.39*10.6
.058+0.0

4.10*10.6
.048+0.0

4.33*10.4
.033*10.0

Li+

mEq/L
mEq/4 hr

7.9+0.4
0.75*10.0

30.5*14.3
.215*10.0

43.1*14.2
.379*10.0

63.3*13.3
.746*10.0

178.9*18.3
1.337*10.1

0
0

14

Figure 7. Lithium
concentration in
serum after oral
administration of
LiCl. Mean increase
in serum Li+ concen
tration (mEq Li+ /L)
is shown as a func
tion of various doses
of LiCl given orally
at 0 hour and -2 hour.
Atomic absorption
did not detect Li+ in
control animals
treated with saline.
Each point represents
the mean value from
eight rats.

-2 HR

E

Figure 8. Lithium
concentration in
serum and gastric
juice. Mean increase
in Li+ concentration
(mEq Li+ /L) is shown
as a function of
LiCl given subcu
taneously at var
ious times before
pylorus ligation.
Atomic absorption
did not detect Li+
in control animals
treated with saline.
Each column repre
sents the mean value
from eight rats.
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S

Table S.

Concentration and output of ions in gastric juice after subcutaneous administration of
lithium chloride at various times before pylorus ligation.
Concentration and output of
ions are expressed as mEq/L and mEq/4 hr respectively.
Each numeral represents the mean
value from eight rats. Numerals to the right indicate standard error.
(* significant
>0.05 level)

Concentration and
output of ions

Saline
Control

0 hr

-2 hr

LiCl 1.0 mMole
-6 hr
-12 hr

- 18 hr

CD

1

H+

mEq/L
mEq/4 hr

117.3±6.2
0.816±0.1

17.5*12.0
0.057*10.0

31.1*13.1
0.117*10.0

36.2*13.3
0.069*10.0

70.6*16.8
0.227*10.0

91.7*15.4
0.509*10.1

+

mEq/L
mEq/4 hr

24.4±1.7
0.17210.0

81.2*11.6
0.275*10.0

94.2*15.2
0.348*10.1

103.7*17.9
0.203+0.0

62.6**7.4
0.179+0.0

38.1*13.7
0.245+0.1

c

a

°
g

CT

.. . . . . . . . .

■

■
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Shay Ulcer Studies
Lithium chloride reduced the incidence of Shay ulcers and of
forestomach perforations.

The acid concentration, however, did not

correlate with ulcer inhibition.

For example, oral treatment with

LiCl (0.75 mMole) reduced the acid concentration by 41% (Table 4)
and did not significantly reduce the incidence of Shay ulcers
(Fig. 9, p. 17); oral treatment with LiCl (1.0 mMole) reduced acid
concentration by only 27% (Table 4), but significantly reduced Shay
ulcers (Fig. 9, p. 17).

Table 4.

Shay ulcer study: volume and acid concentration after
oral or subcutaneous administration at -2 hr. Results
are expressed as percent change from control.
Each
numeral represents the mean value from eight rats.
(* = significant >0.05 level)

mMoles LiCl

Volume and
acid concen
tration of
gastric juice

.75

1.0

1.5

.75

1.0

1.5

Volume
S.E.

+10
±8.2

- 4
±7.2

+10
±7.9

-27*
±6.2

-37*
±5.8

-37*
±6.0 .

Acid
S.E.

-41*
±6.0

-27*
±6.2

-62*
±4.3

-13*
±3.8

-36*
±5.4

-85*
±1.3

Oral

Subcutaneous

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 9. Antiulcer effect of LiCl. Animals
were sacrificed 22 hours after pylorus ligation.
Percent incidence of animals with ulceration and
perforation is indicated by verticle columns.
Numerals next to columns indicate the number of
rats.
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DISCUSSION

Oral administration of LiCl at hypertonic doses appears to
increase gastric mucosal permeability to ions.

These studies indicate

that Na+ concentration increases while K+ and H+ concentrations
decrease in gastric juice after oral administration of LiCl (Table 2,
p. 13).

Apparently, Na+ moves across the gastric wall from serosa to

mucosa while H+ and K+ travel in the opposite direction (from mucosa
to serosa).

Under normal conditions H+ and K+ are found in blood at

lower concentrations than in gastric juice, whereas Na+ is more
concentrated in b l o o d . ^

The observations noted in this study suggest

that oral administration of LiCl at hypertonic doses increases the
+

4-

permeability of the gastric mucosa to H , K , and Na , allowing them
to move more freely across the gastric mucosa in response to their
concentration gradients.

The slight increase in volume observed

with oral administration of NaCl and LiCl at hypertonic doses may
have been due to osmotic p u l l . ^ ^
Other investigators have observed a reduction in acid content
of the gastric juice in dogs after topical application of hypertonic
salt solutions ranging from 1.2 to 2.0 mM.

13 14
’

Frenning and

c o l l e a g u e s ^ attributed their observations to increased mucosal
permeability.

A l t a m i r a n o ^ observed increased mucosal permeability

to Na , K , and Cl

after topical application of hypertonic solutions

of non-electrolytes (e.g., sucrose, glucose, and urea).

Interestingly,

the increase in mucosal permeability to ions is selective; most of

18
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the Li+ remained in the stomach even though other ions (e.g., H+ , K+
and Na+ ) appear to freely move across the gastric wall.
Subcutaneous administration of LiCl caused an increase in Na+
concentration and output in gastric juice regardless of the time of
administration.

The increase in Na+ content of gastric juice, after

LiCl administration, correlates with the inhibition of acid secretion.
Interestingly, this correlation does not appear to result from
permeability changes induced by lithium’s hypertonicity in gastric
juice.

The Li+ content in gastric juice was approximately ten times

higher after oral administration (Table 2, p. 13) as compared to sub
cutaneous administration (Fig. 8, p. 14).

Many investigators have

suggested that H+ and Na+ are exchanged across the gastric mucosa
. i 16-18
mole for mole.
The observation that the lithium ion appears to remain in the
stomach after oral administration (Table 3, p. 15) may be contradictory
to the work of Chung.

19

His work on the canine stomach indicates that

Li+ and H+ move out of the gastric lumen by the same pathway.

His

studies, however, were performed under resting conditions, whereas
the present study was performed under active secretory conditions.
Altamirano

20

suggests that the permeability of the resting mucosa is

greater than that of the actively secreting mucosa.
the efflux of Li+ was not calculated.
gastric juice and serum were measured.

In this study

Only Li+ concentration in
Therefore, the possibility

that Li+ leaves the stomach at approximately the same rate as it is
absorbed by other tissues and/or excreted by the kidney cannot be
excluded.

Chung’s work

19

has stimulated a number of investigators
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20

to explore the possibility of using Li+ as a marker for H+ ion backdiffusion across the gastric mucosa.
Some investigators have found that Li+ is indeed a reliable
marker for back-diffusion of H

^

ions,

convincing evidence against this.

21 23

although Ivey

2^

provided

The data presented in this report

that LiCl is antisecretory, and the fact that Li+ has profound effects
on Na

+

12
transport systems *

further devaluates the possibility of

using Li+ as a marker for back-diffusion of H+ ions.
As described in the Results section,

1) gastric juice was

yellow after both oral and subcutaneous administration of LiCl at
-2 hours, but not at 0 hour,

2) volume was significantly greater

(according to the Sign test) after subcutaneous administration at -2
hours as compared to subcutaneous administration at 0 hour, and
3) pepsin concentration was not reduced after subcutaneous adminis
tration at 0 hour, whereas it was after subcutaneous administration
at -2 hours.

From these results the following are postulated:

1) a duodenal reflux occurs within the first 2 hours after LiCl admin
istration;

2) the reflux might contain trypsin (from pancreatic

secretion) and bile;

3) since the optimal pH for trypsin is around

7.0, the dose-related reduction of acid concentration produced by
LiCl at the -2 hour administration time (Fig. 10, p. 21) may have
caused the concomitant digestion of pepsin by trypsin.

Moreover, the

duodenal reflux may have been alkaline (above pH 7) causing the
irreversible degradation of pepsin.

25

This would denature the

pepsin present at the time of reflux but could not damage the pepsin
released after the gastric pH dropped below 7.0.

The above mechanisms

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

21

ia
in

e

e

i
2
u

a-

1.75

Figure 10.
Acid and pepsin concentration after
subcutaneous administration of LiCl. Mean decrease
of acid and pepsin concentration, expressed as
percent of control, is shown as a function of
various doses of LiCl given subcutaneously at
-2 hour.
Each point represents the mean value
from 10 rats. Verticle bars indicate standard
error.
(* = significant >0.05 level).

would explain the reduction in pepsin concentration by LiCl when
given either orally or subcutaneously two hours before pylorus
ligation, but not when given orally after pylorus ligation.
Although hypertonic solutions of NaCl and LiCl are equipotent
in their ability to reduce acid and pepsin after oral administration
at 0 hour, LiCl is more antisecretory than NaCl at -2 hours.

This

difference may be due to parenteral effects of LiCl not shared by
NaCl.

The evidence for this is as follows:

1) the serum concentra

tion of Li+ after oral treatment at -2 hours is significantly
greater than at 0 hour, and

2) hypertonic solutions of LiCl are
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antisecretory after subcutaneous administration whereas equitonic
solutions of NaCl are not.

Apparently, very little Li+ is absorbed

from the stomach and when administered orally at -2 hours, Li+ enters
the intestine through the pylorus and is absorbed by the small
intestine.

Thus, the reduction of acid by oral administration of LiCl

at -2 hours may result from both increased mucosal permeability and a
parenteral effect.
The duodenal reflux produced by LiCl after administration at
— 2 hours may have contributed to the reduction of acid and pepsin.
The buffering effects of bile and pancreatic bicarbonate may have
reduced the acid and pepsin content, whereas trypsin (from pancreatic
sefcretion) could be responsible for the increased depression of
pepsin content.

Even though the alkaline bile may have buffered the

acid at the time of reflux, the fact that bile is a potent stimulator
of gastric secretion

26

could provide additional evidence that LiCl

is a potent inhibitor of gastric secretion. Furthermore, since LiCl
was antisecretory after subcutaneous administration at 0 hour, that
is, after pylorus ligation, the contribution of duodenal reflux to
parenteral inhibition of gastric acid secretion is small.

Such

reflux could not have occurred when LiCl was administered after
pylorus ligation.
The observation that the concentration of Li+ was higher in
gastric juice i-fran in serum after subcutaneous administration provided
a clue to the mechanism of LiCl in reducing acid secretion.
proposed that Li"*" could substitute for H

We

on the H —pump and that

this might explain the decrease in acid concentration and the high
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Li+ concentration in gastric juice.

To explore this possibility, an

anticholinergic agent, methscopolamine bromide, was administered
(10 mg/kg) at -2 hours subcutaneously, and LiCl was administered at
0 hour at doses of 1.0 and 2.0 mMole subcutaneously.

At that dose,

methscopolamine bromide completely inhibited H+ secretion; however,
methscopolamine bromide had no effect on Li+ concentration in gastric
juice (Table 5).

Table 5.

Effect of saline or methscopolamine bromide administration
on concentration of ions in gastric juice after subcutaneous
administration of lithium chloride at 0 hr. Concentration
of ions was expressed as mEq/L.
(* = significant >0.05
level)

Concentration
of ions in
gastric juice

Saline
Control

Saline
LiCl (mMole)
2.0
1.0
17

17

# Animals

15

H+ (mEq/L)
S.E.

142.2
±4.5

9.65*
±2.6

4.30*
±1.0

0

5.76*
±0.3

11.02*
±0.9

Li+ (mEq/L)
S.E.

Methscopolamine Bromide
Saline
LiCl (mMole)
Control
1.0
2.0
8
1.20
±0.5
0

Since methscopolamine bromide inhibited H

8

7

2.20
±0.6

3.57
±0.7

5.94*
±0.3

12.25*
±1.0

secretion by impairing

vagal stimulation of parietal cells, but had no effect on Li+ accumu
lation in gastric juice, the following was postulated:

1) methscopo

lamine bromide indirectly blocks active transport of H+ by inhibiting
vagal stimulation of parietal cells, and

2) since methscopolamine

bromide did not influence the ability of Li+ to accumulate in
gastric juice, Li+ was not actively transported by the H+ -pump.
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Although the accumulation of Li+ in gastric juice cannot be
attributed to substitution of Li+ for H+ on the H+ -pump, this accumu
lation may be accounted for by other means.
shown that Li

+

Some investigators have

accumulates in cardiac cells of the heart

27

and other

tissues.^- The fact that Li+ can compete with Na+ in passive
transport,

1 2 28
1 2 28-30
* *
but not active transport, ' *
might explain this

phenomenon.

Indeed, Li+ might enter the stomach via the Na+ passive

transport system, acting as though it were Na+ , in response to the Na+
concentration gradient.

Once in the stomach, Li+ might be trapped

there because of its inability to substitute for Na+ on the Na+ -pump.
Moreover, the possibility that renal excretion of Li+ occurs at a
faster rate than Li+ movement out of the stomach cannot be excluded.
Schou^ has suggested this possibility for Li+ accumulation in other
tissues.
Lithium chloride may have reduced gastric secretion by inhibiting
vagal nerve function.

The rat is a spontaneous secretor, secreting

copiously without exogenous stimulation even when fasted.
continuous secretion is mediated by vagal stimulation.

This

The effect of

lithium on the vagus has been described in detail by Ploeger.

31-33

His studies indicate that Li+ is an irreversible competitive inhibitor
of the Na+ /K+ -pump.

Furthermore, Li+ ions have been shown to inhibit

synthesis and release of acetylcholine.

34 35
’

These observations

indicate that LiCl could inhibit gastric secretion by causing vagal
dysfunction.
Lithium might interfer with the cyclic nucleotides thereby in
hibiting gastric secretion.

Lithium chloride inhibits cAMP synthesis
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in a number of tissues:

thyroid, kidney, fat cells, ovary, toad

bladder, and central nervous system.

3

Most investigators concur that

Li+ inhibits cAMP by inhibiting hormone-induced adenylate
2 36 37
cyclase. * *
Whether or not cAMP is necessary for acid secretion
seems to depend upon the species under investigation.
associates

Sewing and

38 39
*
have provided evidence suggesting cAMP mediated

acid secretion in the rat.

Assuming that cAMP is necessary for

gastric secretion, LiCl could inhibit gastric secretion at this
biochemical level.
Even though LiCl inhibited Shay ulcers, ulcer inhibition did
not correlate with acid inhibition.

This may be due to the presence

of blood in the gastric juice of animals with severe ulcerations; the
buffering effect of blood may have neutralized the acid formed.
Lithium chloride offered better protection when administered subcu
taneously than orally (Fig. 9, p. 17).
was complete protection (Fig. 9, p. 17).

Indeed, at 1.5 mMole, there
As shown in Table 5, page 16,

the volume of gastric juice was significantly greater with oral admin
istration.

We hypothesize that,

1) the greater volume observed with

oral treatment distended the stomach and this distension may have
aggravated the ulcers,

and

2) the higher concentration of LiCl in

gastric juice observed with oral administration may have damaged the
gastric mucosa.
The ability of LiCl to prevent the formation of Shay ulcers and
histamine-induced ulcers (unpublished observations) suggests that
lithium may be a potential antiulcer agent.

Additional studies need

to be performed, however, to validate this possibility.
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CONCLUSIONS

1.

Lithium chloride reduces gastric secretion regardless of
the route of administration.

2.

The reduction of gastric secretion after oral administration
is due to lithium hypertonicity and appears to work by
increasing gastric mucosal permeability to ions.

3.

The reduction of gastric acid secretion after subcutaneous
administration is not due to lithium hypertonicity in blood
or gastric juice and appears to result from a parenteral
effect of lithium chloride.

4.

Lithium chloride reduces Shay ulcers and forestomach
perforations regardless of the route of administration.

26
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